Nutrition, Metabolism & Cardiovascular Diseases
Volume 21, Issue 10 , Pages 823-829 , October 2011

Meta-analysis on the effect of the Ala54Thr polymorphism of the fatty acid-binding protein 2 gene on body mass index

  • T. Zhao

      Affiliations

    • Department of Geriatrics, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China
    • Corresponding Author InformationCorresponding author. Tel.: +86 571 887784720; fax: +86 571 87022660.
    • ,
  • J. Zhao

      Affiliations

    • Department of Geriatrics, Hangzhou Hospital of Traditional Chinese Medicine, Hangzhou 310000, China
    • ,
  • J. Lv

      Affiliations

    • Department of Geriatrics, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China
    • ,
  • M. Nzekebaloudou

      Affiliations

    • Department of Food Science Nutrition, Zhejiang University, Hangzhou 310000, China

Received 3 November 2009 ,Revised 9 February 2010 ,Accepted 10 February 2010.

References 

  1. Roditis ML, Parlapani ES, Tzotzas T, Hassapidou M, Krassas GE. Epidemiology and predisposing factors of obesity in Greece: from the Second World War until today. J Pediatr Endocrinol Metab. 2009;5:389–405
  2. Luo W, Morrison H, de Groh M, Waters C, DesMeules M, Jones-McLean E, et al. The burden of adult obesity in Canada. Chronic Dis Can. 2007;4:135–144
  3. Qi L, Cho YA. Gene-environment interaction and obesity. Nutr Rev. 2008;12:684–694
  4. Chakravarthy MV, Zhu Y, Yin L, Coleman T, Pappan KL, Marshall CA, et al. Inactivation of hypothalamic FAS protects mice from diet-induced obesity and inflammation. J Lipid Res. 2009;4:630–640
  5. Yang W, Kelly T, He J. Genetic epidemiology of obesity. Epidemiol Rev. 2007;29:49–61
  6. Berthier MT, Couillard C, Prudhomme D, Nadeau A, Bergeron J, Tremblay A, et al. Effects of the FABP2 A54T mutation on triglyceride metabolism of viscerally obese men. Obes Res. 2001;11:668–675
  7. Baier LJ, Sacchettini JC, Knowler WC, Eads J, Paolisso G, Tataranni PA, et al. An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest. 1995;95:1281–1287
  8. de Luis DA, Sagrado MG, Aller R, Izaola O, Conde R. Influence of ALA54THR polymorphism of fatty acid-binding protein 2 on obesity and cardiovascular risk factors. Horm Metab Res. 2007;11:830–834
  9. Albala C, Santos JL, Cifuentes M, Villarroel AC, Lera L, Liberman C, et al. Intestinal FABP2 A54T polymorphism: association with insulin resistance and obesity in women. Obes Res. 2004;2:340–345
  10. Deurenberg P, Deurenberg-Yap M, Guricci S. Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationship. Obes Rev. 2002;3:141–146
  11. Fisher E, Li Y, Burwinkel B, Kühr V, Hoffmann K, Möhlig M, et al. Preliminary evidence of FABP2 A54T polymorphism associated with reduced risk of type 2 diabetes and obesity in women from a German cohort. Horm Metab Res. 2006;5:341–345
  12. Nakanishi S, Yamane K, Kamei N, Okubo M, Kohno N. The effect of polymorphism in the intestinal fatty acid-binding protein 2 gene on fat metabolism is associated with gender and obesity amongst non-diabetic Japanese-Americans. Diabetes Obes Metab. 2004;1:45–49
  13. Albala C, Villarroel A, Santos JL, Angel B, Lera L, Liberman C, et al. FABP2 Ala54Thr polymorphism and diabetes in Chilean elders. Diabetes Res Clin Pract. 2007;2:245–250
  14. Galluzzi JR, Cupples LA, Otvos JD, Wilson PW, Schaefer EJ, Ordovas JM. Association of the A/T54 polymorphism in the intestinal fatty acid binding protein with variations in plasma lipids in the Framingham Offspring Study. Atherosclerosis. 2001;2:417–424
  15. Brown MD, Shuldiner AR, Ferrell RE, Weiss EP, Korytkowski MT, Zmuda JM, et al. FABP2 genotype is associated with insulin sensitivity in older women. Metabolism. 2001;9:1102–1105
  16. Erkkila AT, Lindi V, Lehto S, Pyorala K, Laakso M, Uusitupa MI. Variation in the fatty acid binding protein 2 gene is not associated with markers of metabolic syndrome in patients with coronary heart disease. Nutr Metab Cardiovasc Dis. 2002;2:53–59
  17. Tahvanainen E, Molin M, Vainio S, Tiret L, Nicaud V, Farinaro E, et al. Intestinal fatty acid binding protein polymorphism at codon 54 is not associated with postprandial responses to fat and glucose tolerance tests in healthy young Europeans. Results from EARS II participants. Atherosclerosis. 2000;2:317–325
  18. Sipilainen R, Uusitupa M, Heikkinen S, Rissanen A, Laakso M. Variants in the human intestinal fatty acid binding protein 2 gene in obese subjects. J Clin Endocrinol Metab. 1997;8:2629–2632
  19. de Luis DA, Sagrado MG, Aller R, Izaola O, Conde R, Romero E. Ala54Thr polymorphism of fatty acid binding protein 2, role on insulin resistance and cardiovascular risk factors in presurgical morbid obesity patients. Obes Surg. 2009;12:[Epub ahead of print]
  20. Lara-Castro C, Hunter GR, Lovejoy JC, Gower BA, Fernández JR. Association of the intestinal fatty acid-binding protein Ala54Thr polymorphism and abdominal adipose tissue in African-American and Caucasian women. J Clin Endocrinol Metab. 2005;2:1196–1201
  21. Georgopoulos A, Aras O, Noutsou M, Tsai MY. Unlike type 2 diabetes, type 1 does not interact with the codon 54 polymorphism of the fatty acid binding protein 2 gene. J Clin Endocrinol Metab. 2002;8:3735–3739
  22. Georgopoulos A, Aras O, Tsai MY. Codon-54 polymorphism of the fatty acid-binding protein 2 gene is associated with elevation of fasting and postprandial triglyceride in type 2 diabetes. J Clin Endocrinol Metab. 2000;85:3155–3160
  23. Oguri M, Kato K, Yokoi K, Itoh T, Yoshida T, Watanabe S, et al. Association of genetic variants with myocardial infarction in Japanese individuals with metabolic syndrome. Atherosclerosis. 2009;2:486–493
  24. Takakura Y, Yoshioka K, Umekawa T, Kogure A, Toda H, Yoshikawa T, et al. Thr54 allele of the FABP2 gene affects resting metabolic rate and visceral obesity. Diabetes Res Clin Pract. 2005;1:36–42
  25. Ishii T, Hirose H, Kawai T, Hayashi K, Maruyama H, Saito I, et al. Effects of intestinal fatty acid-binding protein gene Ala54Thr polymorphism and beta3-adrenergic receptor gene Trp64Arg polymorphism on insulin resistance and fasting plasma glucose in young to older Japanese men. Metabolism. 2001;11:301–307
  26. Kim CH, Yun SK, Byun DW, Yoo MH, Lee KU, Suh KI. Codon 54 polymorphism of the fatty acid binding protein 2 gene is associated with increased fat oxidation and hyperinsulinemia, but not with intestinal fatty acid absorption in Korean men. Metabolism. 2001;4:473–476
  27. Yamada K, Yuan X, Ishiyama S, Koyama K, Ichikawa F, Koyanagi A, et al. Association between Ala54Thr substitution of the fatty acid-binding protein 2 gene with insulin resistance and intra-abdominal fat thickness in Japanese men. Diabetologia. 1997;6:706–710
  28. Hayakawa T, Nagai Y, Nohara E, Yamashita H, Takamura T, Abe T, et al. Variation of the fatty acid binding protein 2 gene is not associated with obesity and insulin resistance in Japanese subjects. Metabolism. 1999;5:655–657
  29. Ito K, Nakatani K, Fujii M, Katsuki A, Tsuchihashi K, Murata K, et al. Codon 54 polymorphism of the fatty acid binding protein gene and insulin resistance in the Japanese population. Diabet Med. 1999;2:119–124
  30. Xiang KS, Zheng TS, Jia WP, Sun DQ, Ding W, Li J, et al. The association of Ala54Thr variant of intestinal Fatty acid binding protein gene with general regional adipose tissue deposits. Chin Med Sci J. 1999;1:46–51
  31. Wang J, Si Q, Fu Y, Wang XD. Polymorphism of the fatty acid-binding protein 2 gene in patients with coronary hear t disease. Int J Emerg and Crit Care Med. 2006;4:1352–1355
  32. Martinez-Lopez E, Ruíz-Madrigal B, Hernández-Canaveral I, Panduro A. Association of the T54 allele of the FABP2 gene with cardiovascular risk factors in obese Mexican subjects. Diab Vasc Dis Res. 2007;3:235–236
  33. Perez-Bravo F, Fuentes M, Angel B, Sanchez H, Carrasco E, Santos JL, et al. Lack of association between the fatty acid binding protein 2 (FABP2) polymorphism with obesity and insulin resistance in two aboriginal populations from Chile. Acta Diabetol. 2006;4:93–98
  34. Vimaleswaran KS, Radha V, Mohan V. Thr54 allele carriers of the Ala54Thr variant of FABP2 gene have associations with metabolic syndrome and hypertriglyceridemia in urban South Indians. Metabolism. 2006;9:1222–1226
  35. Lei HH, Coresh J, Shuldiner AR, Boerwinkle E, Brancati FL. Variants of the insulin receptor substrate-1 and fatty acid binding protein 2 genes and the risk of type 2 diabetes, obesity, and hyperinsulinemia in African-Americans: the Atherosclerosis Risk in Communities Study. Diabetes. 1999;9:1868–1872
  36. Attia J, Thakkinstian A, D'Este C. Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J Clin Epidemiol. 2003;4:297–303
  37. Zintzaras E, Kitsios G, Stefanidis I. Endothelial NO synthase gene polymorphisms and hypertension: a meta-analysis. Hypertension. 2006;4:700–710
  38. Zintzaras E, Chatzoulis DZ, Karabatsas CH, Stefanidis I. The relationship between C677T methylenetetrahydrofolate reductase gene polymorphism and retinopathy in type 2 diabetes: a meta-analysis. J Hum Genet. 2005;6:267–275
  39. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simples, graphical test. BMJ. 1997;315:629–634
  40. Bax L, Yu LM, Ikeda N, Tsuruta H, Moons KGM. Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Med Res Methodol. 2006;6:50
  41. Bax L, Yu LM, Ikeda N, Tsuruta H, Moons KGM. MIX: comprehensive free software for meta-analysis of causal research data. Version 1.7. <http://mix-for-meta-analysis.info>2008;

PII: S0939-4753(10)00069-4

doi: 10.1016/j.numecd.2010.02.020

Nutrition, Metabolism & Cardiovascular Diseases
Volume 21, Issue 10 , Pages 823-829 , October 2011

Article Tools

* Image Usage & Resolution